Nu Skin Enterprises A

Nu Skin reported a 12% decline in revenue to $320.6 million for the first quarter of 2026 and a 14% drop in customer count. Adjusted earnings per share were $0.14, missing analysts' expectations, and the stock fell in after-hours trading. All regions recorded revenue declines; management still expects pressure in 2026 but anticipates sequential improvement and issued a full-year sales outlook of $1.35–1.50 billion. » More on de.investing.com

Nu Skin has launched sales in the US of the portable wellness device Prysm iO, priced at $375. The device measures skin carotenoids via a 15‑second finger scan and uses Spectral Rai technology and AI to generate a "Nutrition Health Score." A published study shows a high correlation with blood serum values and consistent results across skin types; the device is compatible with Nu Skin supplements. Nu Skin plans to expand into additional markets; the stock is currently trading well below the start of the year, but the company reports high gross margins and annual revenue of $1.49 billion. » More on de.investing.com

Nu Skin has named Chelsea Lantz interim chief financial officer effective immediately, after James Thomas resigned following 16 years. The board has launched a formal search for a permanent successor. Lantz, who joined Nu Skin in 2011 and has been corporate controller since 2023, led cost-optimization measures that improved earnings per share; she previously worked at PricewaterhouseCoopers. The stock has lost about 25% year-to-date and is trading at $7.13, with analysts, according to InvestingPro, viewing the shares below their fair value, while the gross margin stands at 69%. » More on de.investing.com